Henry McCusker's  Instablog

Henry McCusker
Send Message
Analyst, Journalist and Publisher ... Henry enters his tenth (10) year at Scimitar Equity -Regenerative Medicine Investors which aggregates, curates and creates bottom-line content weeding of regenerative medicine and cell therapy news to provide a customized, vetted selection of relevant and... More
My company:
Scimitar Equity-Regenerative Medicine Investors
My blog:
Scimitar Equity Blog
  • RegMed Sector's Waiting For Godot, Any Good News Or Was It Bernanke? 0 comments
    Aug 29, 2012 12:32 PM | about stocks: VCEL, CYTX, CLBS, OSIR

    The 6 W's: Who, what, where, when, why and what of it

    Sitting in a thin volume seat, waiting for what again?

    Mid-Day: The NASDAQ is DOWN -0.50 (-0.02%) to 3,076.64 while the Dow is UP +4.19 (+0.03%) to 13,107.18.

    Market Commentary: Stocks struggled to hold their gains Wednesday … My lower opening posting was scuttled, stock-market futures turn up after the government revised … higher estimates of the economy's performance in Q2 … it is good to be wrong !

    Today's Gospel: At least … my favorites are moving! The last week of August is traditionally a vacation week - and I seriously considered skipping … as I was waiting for some … solid news this week. But, there were so many emails that I decided to stay the course with you … even I get nervous when I don't hear much…!

    Stocks added small gains if any … we're still feeling the effects of low volume. Who is playing through today … Osiris (NASDAQ:OSIR), Cytomedix (OTC: CMXI), Cytori (NASDAQ:CYTX), Dendreon (NASDAQ:DNDN) and Opexa (NASDAQ:OPXA) followed NeoStem (NYSE MKT: NBS) and the usual <or unusual suspects> BioTime (NYSE MKT: BTX) and Opexa (OPXA)

    Measuring the day - 12 green (ups) … with 11 red (downs) and 4-5 fluctuating black (flats)… The CBOE Volatility Index traded still … above 16.

    My favorites:

    • Aastrom (ASTM) is UP $0.03 … at $1.64 or +1.86% with a mid-day range of $1.58 - $1.65 with … with small volume … of 76K so, far from Tuesday's $1.58 - $1.62 <versus volume of 134.3K>;
    • BioLife Solutions (OTC: BLFS) is … FLAT at $0.10, again …. I am still backing this … grossly LOW value asset but, their CFO Taylor did get a raise;
    • Cytori (CYTX) is UP +$0.08 or +2.56%…. At $3.21 … in an increasing trading range of $3.11 - $3.21 with trading of 131K shares from Tuesday's $3.00 - $3.15 with <versus 258.7K;
    • Osiris (OSIR) is UP +$0.36 or +4.07% to $9.16 … with an increasing trading range of $8.72 -$9.12 from with still low volume of 96K shares so far from Tuesday's $8.42 - $8.80, with volume of 128.5K>;
    • NeoStem (Amex: NBS) … continues UP … post multiple filings that tidied-up the books and cap table … +0.022 …to $0.63 or +3.56% … in a tighter day's range of $0.62 -$0.64 … with 257K volume from Tuesday's $0.58 -$0.64 and volume of 544.8k.

    Worth mentioning and Reading:

    • Insiders SELL (10b5-1) at Pluristem : YANAY YAKY, CFO sold 20K shares and ABERMAN ZAMI, Chairman and CEO sold 38.7K;
    • Opexa's (OPXA) stock is on the move … It appears that their Chemistry, Manufacturing and Control ("CMC") IND #9853 has been approved by FDA. Could this was the last item needed before the Trial can start?

    Upward moves:

    • Aastrom (ASTM),
    • Advanced Cell Technology (OTC BB: ACTC),
    • BioTime (NYSEMKT:BTX),
    • BioMimetic (NASDAQ:BMTI),
    • Cytori (CYTX)
    • Dendreon (DNDN),
    • Neuralstem (NYSEMKT:CUR),
    • Opexa (OPXA),
    • Osiris (OSIR),
    • ReNeuron (RENE.L).
    • StemCells (NASDAQ:STEM),

    Downward moves:

    • Athersys (NASDAQ:ATHX),
    • Brainstorm (OTC BB: BCLI),
    • Bioheart (OTC BB: BHRT),
    • Fibrocell (OTC BB: FCSC).
    • Geron (NASDAQ:GERN),
    • ImmunoCellular IMUC),
    • International Stem Cell (OTC: ISCO),
    • NeoStem (Amex: NBS),
    • Pluristem (NASDAQ:PSTI),
    • Tengion (TNGN),
    • Thermogenesis (NASDAQ:KOOL),
    • Verastem (NASDAQ:VSTM).


    • BioLife Solutions (OTC BB: BLFS),
    • Biorestoative (PINK: BRTX),
    • Cryo-Cell (OTC BB: CCEL);
    • Cytomedix (OTC BB: CMXI),

    EconoDrama: The US economy fared slightly better than initially thought in Q2, expanding at a 1.7% annual rate, according to the Commerce Department. Still, the growth rate remained too slow to shut the door on further monetary easing from the Fed, keeping futures slightly higher. Pending home sales in July jumped to their highest level in more than 2 years, rising 2.4% to 101.7. Economists surveyed had expected a gain of 1%.

    What's new in the regenerative medicine/stem cell market … see: www.scimitarequity.com/blog

    We are getting closer to: E-News, Actionable Intelligence, Data Analytics and Research - So catch the wave as we are about to launch the new … RegMed …NEWS PORTAL!! The countdown is days away …

    Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

    Stocks: VCEL, CYTX, CLBS, OSIR
Back To Henry McCusker's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


  • ImmunoCellular (OTC BB: IMUC) files to Sell $13.8M of Units via Cowen
    Nov 30, 2011
  • Mid-Day Movers: BioTime (AMEX: BTX), Cytori (CYTX), Geron (GERN), Neuralstem (AMEX: CUR), ReNeuron (RENE.LON), ThermoGenesis (KOOL)
    Oct 26, 2011
More »

Latest Comments

Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.